Skip to main content
. 2020 Dec 30;9:100054. doi: 10.1016/j.mbplus.2020.100054

Table 1.

ADAMTS and diseases or conditions that proceed with an inflammatory component.

ADAMTS Disease/condition Pro-/Anti-inflammatory Mouse modela Cell typeb Substratec
ADAMTS1 Aortic aneurysm and dissections [40,41,43,44] Pro/Anti Inducible whole-body knockout [43], Constitutive whole-body heterozygous [44] Versican [40,41]
Atherosclerosis [31,35,36] Pro/Anti THP-1, macrophages [30,31] Versican [35]
LPS-induced inflammation [7,25] Pro
Regulation of immune populations [21] n.d. Constitutive whole-body knockout [21] Versican [21]
ADAMTS2 Dermatitis and skin dysfunction [[51], [52], [53]] Anti Constitutive whole-body knockout [52] Monocytes, macrophages [53]
ADAMTS4 Aortic aneurysm and dissections [40,42] Pro Constitutive whole-body knockout [42] Versican [40,42]
Atherosclerosis [[30], [31], [32],34] Pro Constitutive whole-body knockout [34] THP-1, macrophages [30,31] Versican [32,34]
Ischemic stroke and CNS disorders [45] Anti
Osteoarthritis [54] Pro Aggrecan [54]
ADAMTS5 Atherosclerosis [30,31] n.d. THP-1, macrophages [30,31]
Influenza virus infection [60] Pro Constitutive whole-body knockout [60] Versican [60]
Osteoarthritis [[54], [55], [56], [57]] Pro Aggrecan [57]
ADAMTS7 Atherosclerosis [30,33,37,38] Pro Constitutive whole-body knockout [38] THP-1, Macrophages [30,33]
ADAMTS8 Atherosclerosis [30] Pro THP-1 [30]
ADAMTS9 Atherosclerosis [30] Pro THP-1 [30]
ADAMTS12 Asthma or allergy [27] Anti Constitutive whole-body knockout [27]
Inflammatory response [26] Anti Constitutive whole-body knockout [26]
Osteoarthritis and rheumatoid arthritis [58,59] Pro COMP [58]
ADAMTS13 Autoimmune encephalomyelitis [62] Anti
Multiple sclerosis [61] Anti
Thrombotic thrombocytopenic purpura [47,50] Anti Von Willebrand Factor [47]
Traumatic microvascular injury [48] n.d. Constitutive whole-body knockout [49] Von Willebrand Factor [48]
ADAMTS14 Skin dysfunction [52] Anti Constitutive whole-body knockout [52]

n.d.: not determined.

a

Mouse models used to study the referred ADAMTS protease in a specific disease or condition.

b

Immune cell type expressing the referred ADAMTS protease.

c

Substrate contributing to the mentioned pro/anti-inflammatory role.